These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4830772)

  • 1. [System and symbols of coarse pharmaceutical dispersions].
    Melichar M
    Cesk Farm; 1974 May; 23(4):132-8. PubMed ID: 4830772
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proposal for specifications concerning the study of dispersed systems (powders, suspensions...) very fine, extra-fine, ultrafine and micro-fine].
    Mayné F; Guyot JC; Traisnel M
    J Pharm Belg; 1976; 31(2):181-90. PubMed ID: 950583
    [No Abstract]   [Full Text] [Related]  

  • 3. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.
    Tinke AP; Vanhoutte K; De Maesschalck R; Verheyen S; De Winter H
    J Pharm Biomed Anal; 2005 Oct; 39(5):900-7. PubMed ID: 16023816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Particle size determination in suspension and emulsion ointments. The modern status of pharmacopoeia requirements].
    Stejskalová E; Safarík L
    Cesk Farm; 1981 Feb; 30(1):21-5. PubMed ID: 7237584
    [No Abstract]   [Full Text] [Related]  

  • 5. Parenteral suspensions.
    Nash RA
    Bull Parenter Drug Assoc; 1972; 26(2):91-4. PubMed ID: 5012208
    [No Abstract]   [Full Text] [Related]  

  • 6. [Standard prescriptions for the formulation of medicinal preparations in pharmacies. I. Suspensions for dermal administration].
    Subert J; Kolár J; Vasková V
    Ceska Slov Farm; 2008 Apr; 57(2):55-7. PubMed ID: 18578413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of physical stability and dissolution rate of celecoxib suspensions by complexation with beta-cyclodextrins.
    Chandra Sekhara Rao G; Satish Kumar M; Mathivanan N; Bhanoji Rao ME
    Pharmazie; 2004 Aug; 59(8):627-30. PubMed ID: 15378853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].
    Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle size analysis of some pharmaceutical suspensions, measured by the pipette method of Andreasen.
    Joos P; Ruyssen R; Hamers Y
    J Pharm Belg; 1970; 25(2):133-51. PubMed ID: 5515737
    [No Abstract]   [Full Text] [Related]  

  • 11. Spray coated pellets as carrier system for mucoadhesive drug nanocrystals.
    Möschwitzer J; Müller RH
    Eur J Pharm Biopharm; 2006 Apr; 62(3):282-7. PubMed ID: 16377161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of microviscometry to study polymer dissolution from solid dispersion drug delivery systems.
    Esnaashari S; Javadzadeh Y; Batchelor HK; Conway BR
    Int J Pharm; 2005 Mar; 292(1-2):227-30. PubMed ID: 15725569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosizing drug particles in supercritical fluid processing.
    Pathak P; Meziani MJ; Desai T; Sun YP
    J Am Chem Soc; 2004 Sep; 126(35):10842-3. PubMed ID: 15339159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactive mixture as a rapid drug delivery system.
    Lee CC; Ong CL; Heng PW; Chan LW; Wong TW
    Drug Dev Ind Pharm; 2008 Feb; 34(2):206-14. PubMed ID: 18302040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z; Xu S; Li S
    Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytostanol tablets reduce human LDL-cholesterol.
    McPherson TB; Ostlund RE; Goldberg AC; Bateman JH; Schimmoeller L; Spilburg CA
    J Pharm Pharmacol; 2005 Jul; 57(7):889-96. PubMed ID: 15969949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on particle size problems. IV. Particle size stabilities during storage of suspensions of hydrocortisone acetate and prednisolone.
    Moller N; Jensen VG
    Dan Tidsskr Farm; 1970; 44(5):79-91. PubMed ID: 5518819
    [No Abstract]   [Full Text] [Related]  

  • 18. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique.
    Douroumis D; Fahr A
    Eur J Pharm Biopharm; 2006 Jun; 63(2):173-5. PubMed ID: 16621482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of the crystallization behavior of poorly soluble drugs in suspensions].
    Rupprecht H; Ziller KH
    Pharmazie; 1981 Apr; 36(4):298. PubMed ID: 7255533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.